Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 1.76 | 23.97 |
| PEG Ratio (TTM) | -0.07 | -2.88 |
| P/S Ratio (TTM) | 1.06 | 9.63 |
| P/B Ratio (TTM) | 0.35 | 19.75 |
| P/FCF Ratio (TTM) | N/A | 21.24 |
| Price to 5YR AVG Earnings Ratio | 0.73 | 31.74 |
| Price to 5YR AVG FCF Ratio | 1.50 | 26.58 |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.98% | 13.71% |
| ROE (TTM) | 21.51% | 61.65% |
| Net Profit Margin (TTM) | 59.46% | 32.99% |
| ROIC 5YR AVG | 22.44% | 40.47% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -11.04% | -39.13% | -10.93% |
| Revenue | 9.39% | 804.21% | 487.40% |
| Net Income | 13.94% | -39.01% | -14.50% |
| Cash Flow | -25.00% | 3,689.96% | 2,238.80% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 9.93 | 2.80 |
| Quick Ratio (TTM) | 25.25 | 2.36 |
| D/E Ratio (TTM) | 0.07 | 1.43 |
| Interest Coverage (TTM) | 2.86 | 17.86 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.64 | 5.67 |
| LTL to 5YR AVG FCF | 0.06 | 3.23 |
| Shares Outstanding Growth 5YR AVG | -0.92% | 54.77% |